DermTech (Nasdaq:DMTK) announced today that it appointed Bret Christensen as president, CEO and a member of the board. Christensen previously served as chief commercial officer at automated insulin delivery technology developer Insulet. He departed last week as part of a handful of executive changes at the company. The new CEO succeeds Dr. John Dobak, who […]